Clinicopathological Conference, Systemic Lupus Erythematosus with Antiphospholipid Syndrome
NEJM 386:1560-1570, Case 12-2022, 2022
Neurosyphilis
NEJM 381:1358-1363, Ropper, A.H.,et al, 2019
Diagnosis and Management of the Antiphospholipid Syndrome
NEJM 378:2010-2021, Garcia, D. & Erkan, D., 2018
Infections of the Nervous System, (Bacterial, Fungal, Spirochetal, Parasitic) and Sarcoidosis, Neurosyphilis
Adams & Victors Principles of Neurology, Chp 32, pg 723, Ropper, A.H.,et al, 2014
Clinicopath Conference: Secondary Syphilis Involving Skin and Optic Nerve (Neurosyphilis)
NEJM 363:865-874, Case 26: 2010, 2010
Neurosyphillis in the Modern Era
JNNP 75:1727-1730, Timmermans,M. &Carr,J., 2004
Progressive Binasal Hemianopia
Lancet 363:1606, Pringle,E.,et al, 2004
Spinal Cord Syphilis Associated with Human Immunodeficiency Virus Infection:A Treatable Myelopathy
Am J Med 91:101-103, Berger,J.R., 1992
Cerebrovascular and Neurologic Disease Associated with Antiphospholipid Antibodies:48 Cases
Neurol 40:1181-1189, Levine,S.R.,et al, 1990
Neurological Disease Associated with Antiphospholipid Antibodies
Ann Neurol 25:221-227, Briley,D.P.,et al, 1989
Clinical Significance of Cerebrospinal Fluid Tests for Neurosyphilis
Ann Neurol 25:50-55, Davis,L.E.&Schmitt,J.W., 1989
Lyme Disease, A Neuro-Ophthalmologic View
J Clin Neuro-ophthalmol 7:185-190, MacDonald,A.B., 1987
Cerebrovascular Ischemia Associated with Lupus Anticoagulant
Stroke 18:257-263, Levine,S.R.&Welch,K.M.A., 1987
The Spectrum of Neurol Dis Assoc with Antiphospholipid Antibd, Lupus Anticoag & Anticardiolipin Antibd
Arch Neurol 44:876-883, Levin,S.R.&Welch,K.M.A., 1987
Ischemic Stroke Associated with Anticardiolipin Antibodies
Stroke 18:1101-1106, Levine,S.R.,et al, 1987
Lymphocytic Meningoradiculitis & Encephalomyelitis Due to B. Burgdorferi:Clinical & Serological Study of 18 Cases
JNNP 50:1565-1571, Sindic,C.J.M.,et al, 1987
Evaluation of Sera From Patients with Lyme Disease in the FTA-ABS Test for Syphilis
Sex Trans Dis 13:232-236, Hunter,E.G.,et al, 1986
Cerebral Infarct, TIA, & Lupus Inhibitor
Neurol 36:1234-1237, Fisher,M.&McGehee,W., 1986
Neurosyphilis
Arch Neurol 42:606-613, Simon,R.P., 1985
False-Positive VDRL & FTA in Cerebrospinal Fluid
JAMA 244:688-689, Madiedo,G.,et al, 1980
Pupil Shape in Syphilis
Milit Med 144:342, Finelli,P.F., 1979
The CSF-FTA Test & the Significance of Blood Contamination
Ann Neurol 6:68-69, Davis,L.E.,et al, 1979
Cerebrospinal Fluid Findings in Asymptomatic Patients with Reactive Serum FTA Antibody Absorption Tests
Ann Neurol 4:524-530, Traviesa,D.C.,et al, 1978
The Spectrum of Primary Blastomycotic Meningitis:A Review of Central Nervous System Blastomycosis
Ann Neurol 3:26, Gonyea,E.F., 1978
Bell's Palsy & Secondary Syphilis:CSF Spirochetes Detected by Immunofluorescence
Ann Neurol 4:378-380, Davis,L.E.,et al, 1978
False Positive Serology in Cerebrospinal Fluid Associated with a Spinal Cord Tumor
Neurol 26:591, Delaney,P., 1976
Lupus Meningitis
Ann Int Med 80:58, Keefe,E.,et al, 1974
Neurologic Manifestations of Progressive Systemic Sclerosis, 1972
Nebraska Med J 58:106, Aita,J.A., 1973
Neurologic Manifestations of SLE 1972
Nebraska State Journ Med, Oct 1972, pp 395., Aita,J., 1972
Neurosyphilis
JAMA 219:726, Hooshmand,H.,et al, 1972
A Collagen Disorder of the Nervous System Presenting As Multiple Sclerosis
Brain 95:373, Fulford,K.,et al, 1972
Seizure Disorder in Neurosyphilis
Neurol 22:400, Hooshmand,H., 1972
The Natural History of SLE by Prospective Analysis
Medicine 50:85, Estes,D.,et al, 1971
Diagnosis & Treatment of Syphilis
NEJM 284:642, Sparling,P.F., 1971
Seronegative Syphilis & the Pupil
in Neuro-Ophthalmology Symposium, U. of Miami, ed. J. L. Smith, St. Louis:C. V. Mosby Co. , 1967, p., 255. r,J.A.,et al, 1967
Seronegative Ocular Syphilis & Neurosyphilis, Neuro-Ophthalmology Symposium, U. of Miami
(Ed) , St. Louis:C. V. Mosby Co. , 1965, p. 1, Smith,J.L., 1965
Epilepsy in SLE
Arch Int Med 88:78, Russell,P.,et al, 1951
Calcitonin Gene-Related Peptide-Targeted Therapy in Migraine: Current Role and Future Perspectives
Lancet 405:1014-1026, Versijpt,J.,et al, 2025
Inebilizumab for Treatment of IgG4-Related Disease
NEJM 392:1168-1177, Stone,J.H.,et al, 2025
Beyond Glucocorticoids for IgG4-Related Disease
NEJM 392:1232-1233, Spiera,R., 2025
Risk of False Acetylcholine Receptor Autoantibody Positivity by Radioimmunoprecipitation Assay in Clinical Practice
Neurol 104:e213498, Zara,P.,et al, 2025
Upadacitinib - An Up-and-Comer for Treatment of Giant-Cell Arteritis
NEJM 392:2062-2064, Koster,M.J. & Warrington,K.J., 2025
Cancer-Related Cognitive Impairment in Patients with Lung Cancer
Neurol 104::e213651, Simo,M.,et al, 2025
A 69-Year-Old Woman with Ophthalmoplegia
Neurol 104:e213763, Yu, H & Frey, J, 2025
A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis
NEJM 392:2309-2320, Nowak,R.J.,et al, 2025
Myasthenia Gravis - Redemption for B-Cell Depletion
NEJM 392:2382-2384, Wolfe,G.I. & Shelly,S., 2025
Efficacy and Safety of Ofatumumab Treatment for Anti-NMDA Receptor Autoimmune Encephalitis (OFF-AE): A Prospective, Multicenter Cohort Study
Ann Neurol 98:80-92, Guo,K.,et al, 2025
A 60-Year-Old Man with Rapidly Progressive Left Hemibody Weakness and Vision Loss
Neurol 105: e213869, Rock,M.,et al, 2025
Pan-Neurofascin Nodo-Paranodopathy Presenting as Fulminant Guillain-Barre Syndrome
Neurol 105:e213848, Cabral,A.,et al, 2025